Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Non Operating Income (2016 - 2025)

Jaguar Health (JAGX) has disclosed Non Operating Income for 11 consecutive years, with -$94000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 155.95% to -$94000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $718000.0, a 1111.27% increase, with the full-year FY2024 number at $51000.0, down 74.5% from a year prior.
  • Non Operating Income was -$94000.0 for Q3 2025 at Jaguar Health, down from $322000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.4 million in Q4 2022 to a low of -$1.1 million in Q2 2022.
  • A 5-year average of $40315.8 and a median of $10000.0 in 2021 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 8220.0% in 2022; the steepest drop was 6675.0% in 2022.
  • Jaguar Health's Non Operating Income stood at -$749000.0 in 2021, then skyrocketed by 281.58% to $1.4 million in 2022, then tumbled by 81.18% to $256000.0 in 2023, then surged by 47.66% to $378000.0 in 2024, then plummeted by 124.87% to -$94000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Non Operating Income are -$94000.0 (Q3 2025), $322000.0 (Q2 2025), and $112000.0 (Q1 2025).